Telomerase-specific oncolytic immunotherapy for promoting efficacy of PD-1 blockade in osteosarcoma.
Mochizuki Y, Tazawa H, Demiya K, Kure M, Kondo H, Komatsubara T, Sugiu K, Hasei J, Yoshida A, Kunisada T, Urata Y, Kagawa S, Ozaki T, Fujiwara T.
Mochizuki Y, et al.
Cancer Immunol Immunother. 2021 May;70(5):1405-1417. doi: 10.1007/s00262-020-02774-7. Epub 2020 Nov 5.
Cancer Immunol Immunother. 2021.
PMID: 33151368
Free PMC article.